Headache Attributed to Vaccination Against COVID-19 (Coronavirus SARS-CoV-2) with the ChAdOx1 nCoV-19 (AZD1222) Vaccine: A Multicenter Observational Cohort Study

INTRODUCTION: The most frequently reported neurological adverse event of ChAdOx1 nCoV-19 (AZD1222) vaccine is headache in 57.5%. Several cases of cerebral venous thrombosis (CVT) have developed after vaccination. Headache is the leading symptom of CVT. For the differential diagnosis of headaches att...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Pain Ther
Prif Awduron: Göbel, Carl H., Heinze, Axel, Karstedt, Sarah, Morscheck, Mascha, Tashiro, Lilian, Cirkel, Anna, Hamid, Qutyaba, Halwani, Rabih, Temsah, Mohamad-Hani, Ziemann, Malte, Görg, Siegfried, Münte, Thomas, Göbel, Hartmut
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Springer Healthcare 2021
Pynciau:
Original Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC8314854/
https://ncbi.nlm.nih.gov/pubmed/34313952
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40122-021-00296-3
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg